Innovation Asset Group
 
Customers that use Decipher for Intellectual Asset & Contract Management

Decipher IP Edition
Transform the way you manage your IP assets. This unique system delivers an ongoing, holistic view of your entire IP portfolio, with tools to stay on top of every aspect of your innovation lifecycle.
Decipher IP Edition Decipher IP Edition

Decipher Contracts Edition
Take control of your corporate contracts and agreements. This powerful, easy-to-use system delivers a centralized view of all your commitments, proactive alerts and quick access to terms and clauses.
Decipher Contracts Edition Decipher Contract Edition

 

     
Customers that use Decipher for Intellectual Asset & Contract Management
Decipher™ is hard at work across a broad spectrum of industries managing intellectual property assets & contracts, including:
  • Biotechnology
  • Branded Consumer Goods
  • Environmental Sciences
  • Financial Services
  • Industrial Manufacturing & Materials
  • Licensing
  • Medical Devices
  • Media & Entertainment
  • Packaging
  • Pharmaceuticals
  • Semiconductors
  • Telecommunications
Let Decipher™ help you optimize the value of your IP and improve the efficiency and management of your licensing and contracts. These companies do:

Revivicor Revivicor’s vision is the commercialization of therapies that can treat and cure serious human disease through regenerative medicine; namely, the replacement of cells, tissues, and organs. Revivicor's focus is the commercialization of treatments for diabetes and whole organ transplantation, developed from the significant advances made in the fields of xenografts and tolerance technologies, which are core competencies of Revivicor.

COM DEV COM DEV, based in Cambridge, Ontario is the largest Canadian-based designer and manufacturer of space hardware subsystems. COM DEV, with facilities in Canada and the United Kingdom, manufactures advanced products and subsystems that are sold to major satellite prime contractors for use in communications, space science, remote sensing and military satellites.

DiagnoCure, Inc. DiagnoCure, Inc. is a world leader in the development, production and commercialization of cell-based and molecular assay platforms for the detection of cancer. Founded in 1994 in Quebec, DiagnoCure commercialized its first diagnostic test in Europe in 1998, obtaining clearance from the FDA for commercialization in the United States in 2000. DiagnoCure’s research and development endeavors include a range of cancer studies and products.

TriQuint Semiconductor
TriQuint Semiconductor supplies high-performance modules and components to the world’s leading communications companies in markets that include wireless handsets,base stations, broadband communications, military and foundry services.

Legacy Health System
The Legacy system provides an integrated network of healthcare services, including acute and critical care, inpatient and outpatient treatment, community health education and a variety of specialty services.

LI-COR
LI-COR Biosciences is a leader in the design, marketing and manufacturing of integrated instrumentation systems for the biotechnology, plant biology, pharmaceutical and environmental research industries.

Eid
Eid Passport® integrates leading edge products and services into solutions that combine identity authentication, background screening and access management to make facilities, assets and people safer and more secure.

Innovation Asset Group Customer Quotes
We couldn’t afford NOT to implement Decipher. Now we have better strategic eyesight with complete visibility of our IP portfolio, its revenue-generating license agreements and our outbound commitments.

-Brad Roth, Ph.D.,
Licensing and Intellectual Property Manager,
LI-COR, Inc., a leading biotechnology instrumentation company.
Innovation Asset Group Customer Quotes

Decipher In Action: request a Live Demo

Stay Informed: Sign up for our newsletter

Download Decipher Product Data Sheets

Download White Papers

Contact Innovation Asset Group

Visit Our Blog:
Join Innovation Asset President and CEO Peter Ackerman and guest IP experts for ongoing dialog on Financial Aspects of Intellectual Property.

The Chief IP Counsel, the CEO and Business Strategy
Aligning IP Strategy and Business Strategy
The IP Audit: Driving by the Rear-View Mirror
Business Strategy IS Intellectual Property Strategy
IP Culture - a Political Priority?
:: View all posts



 
Home | Products | Services | Customers | Resources | News | Partners & Resellers | About Us | Terms & Conditions | Privacy Statement | Contact Us | Sitemap
All Content © 2007 Innovation Asset Group, Inc. All Rights Reserved.
Revealing Hidden Value in IP